Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 1/20 | 0.33 |
| ▸ | RCOR1 | Q9UKL0 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | HTR2C | P28335 | 1/20 | 0.30 |
| ▸ | HTR2B | P41595 | 1/20 | 0.30 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1453390 | 0.91 | ALDH1A1 (0.34) | KDM1ARCOR1ALDH1A1MAPK1HTR2C | |
| SCHEMBL1451928 | 0.84 | ALDH1A1 (0.34) | KDM1ARCOR1ALDH1A1MAPK1HTR2C | |
| SCHEMBL2973975 | 0.76 | ALDH1A1 (0.35) | KDM1AALDH1A1MAPK1NPC1RAB9A | |
| SCHEMBL2972933 | 0.75 | SLC6A2 (0.35) | ALDH1A1MAPK1HTR2C | |
| SCHEMBL4650828 | 0.73 | ALDH1A1 (0.32) | ALDH1A1MAPK1NPC1RAB9A | |
| SCHEMBL1453496 | 0.73 | ALDH1A1 (0.32) | ALDH1A1MAPK1NPC1RAB9A | |
| SCHEMBL1453397 | 0.73 | RAB9A (0.37) | ALDH1A1MAPK1NPC1RAB9A | |
| SCHEMBL2965307 | 0.72 | TP53 (0.33) | ALDH1A1MAPK1HTR2C | |
| SCHEMBL1453732 | 0.72 | CYP1A2 (0.38) | ALDH1A1 | |
| SCHEMBL1452035 | 0.71 | ALDH1A1 (0.40) | ALDH1A1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7763562-B2 | Heteroatom bridged metallocene compounds for olefin polymerization | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2010-07-27 | — | — | US | disclosed |
| US-20070135597-A1 | Heteroatom bridged metallocene compounds for olefin polymerization | EXXONMOBIL CHEMICAL PATENTS INC. | 2007-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070135597-A1 | Heteroatom bridged metallocene compounds for olefin polymerization | AP2M1, AP1M1, PYM1 | KDM1A 3280/4885RCOR1 2210/4885ALDH1A1 4332/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.